Cyrus S. Poonawalla | |
---|---|
Born | 1941 82) | (age
Nationality | Indian |
Education | Brihan Maharashtra College of Commerce |
Occupation(s) | Businessman, owner of Bilthoven Biologicals, Serum Institute of India, Poonawalla Fincorp |
Years active | 1966 – present |
Known for | Founder of Serum Institute of India and owner of Poonawalla Group of Companies |
Spouse | Villoo Poonawalla (died 2010) |
Children | Adar Poonawalla |
Awards | Padma Shri (2005), Padma Bhushan (2022) |
Website | cyruspoonawalla |
Cyrus S. Poonawalla (born in 1941) is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India. [1] [2] In 2022, he is ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. [3] He is ranked number 1 on the Hurun Global Healthcare Rich List 2022. [4]
Cyrus Poonawalla was born in a Gujarati Parsi (Zoroastrian) family. [5] He is the son of Soli Poonawala, who was a horse breeder.
Poonawalla founded the Serum Institute of India in 1966 and built it to the largest vaccine manufacturer (by doses) in the world. Serum produces over 1.5 billion doses annually of a range of vaccines, including for measles, polio and flu. [6]
Poonawalla was married to Villoo Poonawalla, who died in 2010. [7] [8] They have a son, Adar, who currently works as the CEO of Serum Institute of India. [6] He has two grandchildren.
In May 2019, it was reported that Poonawalla, in partnership with Naum Koen, had proposed supplying Ukraine with 100 thousand doses of the measles vaccine for free vaccination. [22] [23]
Azim Hashim Premji is an Indian businessman and philanthropist, who was the chairman of Wipro Limited. Premji remains a non-executive member of the board and founder chairman. He is informally known as the Czar of the Indian IT Industry. He was responsible for guiding Wipro through four decades of diversification and growth, to finally emerge as one of the global leaders in the software industry. In 2010, he was voted among the 20 most powerful men in the world by Asiaweek. He has twice been listed among the 100 most influential people by Time magazine, once in 2004 and more recently in 2011. For years, he has been regularly listed one among The 500 Most Influential Muslims. He also serves as the Chancellor of Azim Premji University, Bangalore. Premji was awarded Padma Vibhushan, India's second highest civilian award, by the Government of India.
Anil Manibhai Naik is an Indian industrialist, philanthropist and the Chairman Emeritus of Larsen & Toubro Limited, an Indian engineering conglomerate, and a former Chairman of the National Skill Development Corporation.
Devi Prasad Shetty is an Indian entrepreneur and cardiac surgeon who is the chairman and founder of Narayana Health, a chain of 21 medical centers in India. He has performed more than 100,000 heart operations. In 2004 he was awarded the Padma Shri, the fourth highest civilian award, followed by the Padma Bhushan in 2012, the third highest civilian award by the Government of India for his contribution to the field of affordable healthcare.
Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Prakash Baba Amte is a social worker from Maharashtra, India. Amte and his wife, Mandakini Amte, were awarded the Magsaysay Award for 'Community Leadership' in 2008 for their philanthropic work in the form of the Lok Biradari Prakalp amongst the Madia Gonds in the Gadchiroli district of Maharashtra and the neighbouring states of Telangana and Madhya Pradesh. In November 2019 he was awarded with ICMR Lifetime Achievement Award by Bill Gates.
Natarajan Chandrasekaran is an Indian businessman, and the chairman of Tata Sons. He was chief operating officer (COO) and executive director of Tata Consultancy Services (TCS), where in 2009, he became chief executive officer (CEO). He was also the chairman of Tata Motors and Tata Global Beverages (TGB). He became the first non-Parsi and professional executive to head the Tata Group. He has assumed the chair of B20 India and will lead the business agenda during India's G20 presidency.
Prathap Chandra Reddy is an Indian entrepreneur and cardiologist who founded the first corporate chain of hospitals in India, the Apollo Hospitals. India Today ranked him 48th in its 2017 list of India's 50 most powerful people.
Azad Moopen is an Indian healthcare entrepreneur. He is the developer of many healthcare facilities in Asia-Pacific. He is also the chairman and managing director of Aster DM Healthcare, a healthcare conglomerate in the Middle East and India founded in 1987.
Thumbay Moideen is an Indian businessman based in Dubai, United Arab Emirates. He is the founder and president of the Thumbay Group, a diversified international business conglomerate headquartered in the Dubai International Financial Centre, with operations across 20 sectors.
Balram Bhargava is an Indian physician scientist, cardiologist, medical educationist, and innovator. He is currently serving as the Chief of Cardiothoracic Centre, AIIMS. He is the former Director General at the Indian Council of Medical Research, New Delhi and secretary of the Department of Health Research; a division under Ministry of Health and Family Welfare, Government of India.
Niranjan Hiranandani is an Indian billionaire businessman, co-founder and managing director of Hiranandani Group, engaged in real estate business. He is ranked by Forbes among the 100 richest Indians, with a net worth of US$1.6 billion as of June 2021.
Raghu Ram Pillarisetti is an Indian surgeon, and the Founder and Director of KIMS-Ushalakshmi Center for Breast Diseases at KIMS Hospitals. Pillarisetti is the founder of Ushalakshmi Breast Cancer Foundation, a not-for-profit organisation, and Pink Connexion, a quarterly newsletter about breast healthcare.
Adar Poonawalla is an Indian businessman. He is the chief executive officer (CEO) of Serum Institute of India and Chairman of Poonawalla Fincorp. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.
Biotechnology in India is a sunrise sector within the Indian economy. Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion. Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.
Arvind Lal is an Indian billionaire, pathologist, medical administrator and the chairman and managing director of Dr Lal PathLabs, a medical diagnostic centre in Delhi. A medical graduate and a medical academic, he is reported to have modernized Indian medical diagnostics and initiated the first Public Private Partnership (PPP) in the field of laboratory testing in India. He holds the rank of a Brigadier in the Indian Armed Forces, an honorary rank conferred by the Army. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Medicine.
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.
Krishna Ella is an Indian scientist and entrepreneur. He is the founder and chairman of Bharat Biotech where he is also a Managing Director. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin.
Suresh Jadhav was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry. At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield.
Pragya D. Yadav is an Indian scientist at the ICMR-National Institute of Virology (NIV), who is known for her research contributions in the field of communicable diseases and highly pathogenic viral infections, such as Crimean–Congo hemorrhagic fever (CCHF), Nipah, Ebola, leading to improvising national public health surveillance policy for interventions and management. Yadav is among the scientists who detected the first three COVID-19 pandemic cases in India. She headed the team that developed Covaxin, the first indigenous COVID-19 vaccine in India